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ON human  endothelial  cells  from  umbilical  cord
(HUVEC) are present, in addition to E- and P-selectins,
their cognate ligands. Differently from selectins, the
ligand expression is constitutive and not modulated
by interleukin-1b . Such ligands appear to be different
from the ones present in promyelocytic cells in order
to  promote  cell  adhesion  to  immobilized  selectins.
The  expression  of  selectin-ligands  on  HUVEC  cells
suggest  that  selectins can participate in endothelial
signalling  besides  their  role  as  adhesion  molecules
for circulating blood cells. However, despite their role
in chemotaxis, selectins do not contribute to HUVEC
tube formation in Matrigel.
Key  words:  adhesion  molecules,  selectin  ligand,  tube
formation, endothelial adhesion, HUVEC
Introduction
The selectins initiate many critical interactions among
blood cells and the vascular system. The recognition
between  E-  and  P-selectins  expressed  on  activated
endothelium and cognate ligands expressed on mye-
loid and lymphoid cells mediates the initial attachment
of leukocytes to venular endothelial cells before their
firm adhesion and diapedesis at sites of tissue injury
and inflammation.1 Besides their main role as adhesion
molecules, selectins have been reported to participate
in angiogenesis responses.2 Soluble E-selectin has been
demonstrated  to  promote  human  endothelial  cell
migration and to stimulate angiogenesis in the rat cor-
nea.3 In an in vitro model of angiogenesis, the forma-
tion of tube-like structures by bovine capillary endo-
thelial cells was inhibited by the addition of an anti-E
selectin antibody.4 P-selectin, as well as E-selectin, rec-
ognizes sialylated glycans such as sialyl-Lewis X and
sialyl-Lewis A containing molecules.5These molecules
have also been implicated in capillary tube formation.4
Consistently,  we  recently  reported  that  soluble
P-selectin can also promote human and bovine endo-
thelial  cell  migration.6 The  expression  of  cognate
ligands on endothelial cells is mandatory to support a
role for selectins as molecules involved also in endo-
thelial signalling and cross-talks. In this study we have
assessed whether quiescent or interleukin-1b (IL-1b )
primed cultured human endothelial cells possess mole-
cules able to recognize E- and P-selectins and their
effect in mediating endothelial functions such as adhe-
sion and morphogenesis of capillary-like structures.
Materials and Methods
Cell lines and culture conditions
Human  umbilical  cord  vein  endothelial  cells
(HUVEC)  were  isolated  with  collagenase  perfusion
of term umbilical cords as previously described7 and
primary  cultures  were  used  in  the  experiments.
HUVEC were grown in Medium 199 supplemented
with  10%   heat-inactivated  fetal  calf  serum  (65°C,
30min). Undifferentiated human  promyelocytic cell
lines HL-60 and U937, obtained from the American
Type Culture Collection (Rockville, MD), were man-
tained in RPMI 1640 containing 10%  heat-inactivated
fetal bovine serum.
Reagents
Human  recombinant  basic  fibroblast  growth  factor
(bFGF)  was  purchased  from  Boehringer  Mannheim
(Germany).  Human  soluble  E-  and  P-selectins  were
purchased from R&D System Europe Ltd, Abingdon,
UK. The  E-selectin–immunoglobulin  fusion  protein
was  kindly  provided  by  Dr  M.  Bevilacqua.  The
following  murine  monoclonal  antibodies  (MoAb)
were used: anti-human E-selectin, BBA 2 (R&D System
Europe  Ltd);  anti-human  P-selectin,  AC1.2  and
BMS126 (Becton Dickinson, San Jose, CA and Bender
Med-System, Vienna, Austria, respectively); anti-Sialyl-
Lewis  X,  CSLEX1  (Becton  Dickinson). The  second
step antibody conjugates were: alkaline phosphatase
goat anti-mouse total immunoglobulin (Ig) (Oncogene
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phatase conjugated goat anti-human IgG (Fc specific)
(SIGMA Chemical Co., St Louis, MO).
Cell-ELISA assays
Confluent HUVEC (5 3 104 cells/well) stimulated or
not  with  100U/ml  of  recombinant  human  IL-1b
(specific  activity  1.3  3 107 U/mg;  Janssen  Biochi-
mica, Beerse, Belgium) for 4h at 37°C or HL-60 cells
(3  3 105 cells/well; immobilized on 96-well  plates
coated  with  0.1mg/ml  of  poly-D-lysine,  MW  >
300000;  Sigma)  were  used  in  cell-ELISA  experi-
ments. Briefly, cells were washed in PBS and incu-
bated  for  1h  at  4°C  in  PBS  containing  1%  bovine
serum albumin with primary MoAbs, the E-selectin-
Ig fusion protein or the complex formed by soluble
P-selectin  and  the  corresponding  non-neutralizing
MoAb AC1.2. After  washings,  the  appropriate  alka-
line-phosphatase conjugated goat anti-mouse total Ig
or  anti-human  IgG  were  added  to  the  wells  for
45min. Specific binding was calculated by subtract-
ing the signal generated (conversion of phosphatase
substrate) in the wells containing cells treated only
with  the  appropriate  alkaline-phosphatase  conju-
gated  goat  anti-Ig.  All  samples  were  assayed  in
triplicate.
Cell adhesion assay
Cell adhesion assays were based on the procedure of
Martens  et  al.,8 with  some  modifications.  Briefly,
soluble  E-  and  P-selectins  were  immobilized  on
96-well plates in carbonate buffer NaHCO3 Na2 CO3
0.05M  pH  9.6  (5m g/ml  overnight  at  4°C  and
10m g/ml  1h  at  room  temperature  for  E-  and
P-selectins,  respectively). The  plates  were  then  sat-
urated with PBS containing 1% bovine serum  albu-
min.  HL-60,  U937  and  HUVEC  cells  (stimulated  or
not with 100U/ml of recombinant human IL-1b for
4h  at 37°C  and then detached from culture plates
by trypsinization) were added at 2 3 105 cells/well
to the selectin-coated wells and incubated at room
temperature  for  45min.  Non-specific  binding  was
determined  in  wells  treated  only  with  carbonate
buffer. Wells were washed gently twice with PBS and
the  adherent  cells  were  labelled  with  0.5mg/ml
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide  (MTT).  The  absorbance  was  read  in  a
photometer  Microplate  3550  at  two  wavelengths
(690nm and 570nm as reference). In some experi-
ments, HL-60 and U937 cells labelled with 2m Ci/ml
[3H]-methyl-thymidine  (NEN-Du  Pont  DeNemours
Italiana, Cologno Monzese (MI), Italy, 82.5Ci/mmol)
for 18h, were used for the cell adhesion assays. 3H
radioactivity was determined by counting in a Wallac
BetaplateTM liquid scintillation counter.
In vitro angiogenesis model
Morphogenetic experiments were performed accord-
ing to the procedures of Wiedermann et al.9 Briefly, a
complete differentiation of HUVEC into capillary-like
structures,  was  achieved  by  coating  24-well  plates
with 300m l of Matrigel (Becton Dickinson, Bedford,
MA, USA) per well, which was allowed to polymerize
at  37°C  for  30min.  For  suboptimal  stimulation  of
HUVEC  differentiation,  300m l  per  well  of  diluted
Matrigel  (1:2  with  Medium  199)  was  kept  at  4°C
overnight for slow polymerization, followed by 37°C
for 30min before use. These suboptimal conditions
were selected in order to better detect factors that
promote tube-formation. HUVEC were suspended in
Medium  199  +  10%  FCS  (105 cells  per  well),
incubated  for  30–40min  at  37°C  with  different
concentrations of test substances and then plated on
diluted Matrigel. Each condition was tested in tripli-
cate wells. After 12–18h of incubation at 37°C in 5%
CO2, the capillary-like structures were observed by
inverted  microscopy  and  quantitatively  evaluated
counting tubular formations ‡  300m m at 303 magni-
fication and using an ocular grid.
Results
Cognate ligands for E- or P-selectins in HUVEC
cells
To determine whether HUVEC cells express ligands for
selectins,  cell  ELISA  experiments  were  performed
using the E-selectin–immunoglobulin fusion protein to
recognize structures that bind E-selectin and a com-
plex of soluble P-selectin with a corresponding non-
neutralizing MoAb (AC1.2) to recognize ligands for P
selectin.  Moreover,  MoAbs  against  sialyl-Lewis  X,
E-selectin and P-selectin were applied. The human pro-
myelocitic cell line HL-60 immobilized on plate surface
coated  with  poly-D-lysine,  endowed  with  P-  and
E-selectin ligands,10,11 was used as a positive control.
As shown in Table 1, molecular structures able to bind
both E- and P-selectin were found on cultured HUVEC
cells. The MoAb CSLEX1 that recognizes sialyl-Lewis
X,12 a  carbohydrate  mojety  bearing  on  ligands  for
selectins,5 did not react above the background levels
on HUVEC cells while was strongly recognized on HL-
60.  As  expected,  the  reactivity  of  MoAb  against
E-selectin  was  detected only on HUVEC  stimulated
with IL-1b while no reactivity for P-selectin was found.
On the other hand, IL-1b exposure did not affect the
expression of E- or P-selectin cognate ligands.
Role of E- and P-selectin cognate ligands on cell
adhesion mediated by immobilized selectins
The  function  of  ligands  for  E-  and  P-selectins
expressed on HUVEC was checked on adhesion assays
to  immobilized  selectins  in  static  conditions.  As
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lized E- or P-selectin within 45min of exposure time.
Consistent with the lack of effect of IL-1b on selectin-
ligand  expression,  the  cytokine  treatment  did  not
improve HUVEC adhesion. The human cell line HL-60
and U937 which express ligands for selectins adhered
strongly to immobilized E- or P-selectins. This adhe-
sion was selective and specific since it was blocked by
the respective neutralizing MoAbs against E- (BBA2)
or  P-selectins  (BMS  126).  In  fact,  MoAb  BBA2
(5m g/ml)  inhibited  HL-60  or  U937  adhesion  to
immobilized E-selectin  of  62  ± 3.6% and 67  ±  8% ,
respectively  (n =  3),  while  left  inalterated the  cell
adhesion  to  P-selectin.  Conversely,  MoAb  BMS126
(10m g/ml)  did  not  influence  static  adhesion  to
E-selectin  but  strongly  blocked  the  HL-60  or  U937
adhesion to P-selectin with inhibition of 92 ± 1% or 87
± 4% , respectively (n = 3).
Role of E- and P-selectins in in vitro assay for
vascular morphogenesis
We  then  assessed  whether  the  presence  of  E-  and
P-selectin  ligands  on HUVEC  cells  could  be  instru-
mental to morphogenetic processes required in angio-
genesis.  The  addition  to  Matrigel  diluted  1:2  of
increasing  concentrations  of  the  angiogenic  factor
bFGF , dose-dependently stimulated HUVEC to prog-
ress from small fragments of unconnected tubes or
cell  aggregates  into  capillary-like  structures  within
18h (Figs 1 and 2). However, soluble E- or P-selectins
(20–2000ng/ml) did not elicit HUVEC differentiation
in  Matrigel  diluted  1:2  (Fig.  2)  although  the  same
concentrations were efficient in promoting HUVEC
chemotaxis.3,6 In addition, soluble selectins or neu-
tralizing  MoAbs anti-E-  or  anti-P-selectin  (BBA2 and
BMS126  up  to  20m g/ml)  did  not  modulate  bFGF-
induced tube-formation (data not shown).
Discussion
The role of selectins in angiogenesis2 and in particular
the effects  of soluble E- and P-selectins on HUVEC
migration reported by Koch and us,3,6 suggested the
presence  of  receptive  molecules  for  selectins  on
endothelial cells themselves. A cell-ELISA assay based
on direct binding of E- and P-selectins was used to
answer this question and also to overcome the aspect
HUVEC E-and P-selectin ligands
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Table 1. Detection of selectins and their cognate ligands on HUVEC and HL-60 cells through cell-ELISA assays
HUVEC
Unstimulated IL-1b -stimulated
HL-60
MoAb anti-sialyl-Lewis X 0 ± 0a 0 ± 0 0.673 ± 0.01
(CSLEX 5m g/ml)
MoAb anti E-selectin 0 ± 0 0.746 ± 0.04 0 ± 0
(BBA2 10m g/ml)
MoAb anti P-selectin 0 ± 0 0 ± 0 0 ± 0
(AC1.2 10m g/ml)
P-selectin binding 0.533 ± 0.1 0.477 ± 0.1 0.445 ± 0.1
(sP-selectin 10m g/ml + MoAb AC1.2 10m g/ml)
E-selectin binding 0.113 ± 0.03 0.110 ± 0.02 0.126 ± 0.01
(E-selectin-Ig fusion protein 50m g/ml)
aMean  of absorbance  (obtained  subtracting  the signal generated  in the  wells containing cells treated  only with the  appropriate  alkaline-
phosphatase conjugated goat anti-Ig) ± SD of three independent experiments.
Table 2. HL-60, U937 and HUVEC cells adhesion on immobilized E- and P-selectins in static assays
Cellsa Assaysb Adhesion
E-selectin Without
E-selectin
P-selectin Without
P-selectin
HL-60 c.p.m. 39639 ± 6176c 387 ± 63 18887 ± 6176 148 ± 42
o.d. 0.683 ± 0.01 0 ± 0 0.330 ± 0.03 0 ± 0
U937 c.p.m. 19124 ± 3907 357 ± 44 17078 ± 3870 436 ± 124
o.d. 0.937 ± 0.1 0 ± 0 0.700 ± 0.08 0 ± 0
HUVEC o.d. 0 ± 0 0 ± 0 0 ± 0 0 ± 0
IL-1b stimulated HUVEC o.d. 0 ± 0 0 ± 0 0 ± 0 0 ± 0
aHL-60, U937, HUVEC and IL-1b -stimulated HUVEC cells (2 3 10
5 cells/well) were incubated for 1h at R.T. in wells coated with immobilized E- and
P-selectins or in wells treated only with carbonate buffer.
bThe bound cells were expressed in c.p.m. in assays with radiolabelled cells or in o.d. in colorimetric assays.
cThe results are reported as mean ± SEM of three independent experiments.relative to the multiplicity of selectin ligands isolated
until  now  in myeloid or  cancer  cells.5,13–15 In this
experimental condition we identified a constitutive
presence of cognate ligands for E- and P-selectins on
HUVEC cells. These structures could be responsible
for transducing signalling inside the cells, since the
endothelial responses to soluble form of selectins.3,6
In addition, this ability was already proved for some
E-selectin  ligands,  such  as  ESL-1,  a  variant  of  FGF
receptor.16 The presence of such signalling-receptor
on  HUVEC  cells  may  suggest  that  they  can  be
activated  not  only  by  soluble  selectins,  present  in
blood  circulation  following  shedding of  membrane
bound  selectins,17 but  also  by  the  transmembrane
selectins expressed in neighbouring activated endo-
thelial cells or by the P-selectin present in platelets.
Moreover  they  could  be  involved  in  activation  of
other  endothelial  functions  during  inflammatory
process, besides their role in chemotaxis. In addition,
the  appearance  of  cellular  function in  response  to
such  interactions  is  regulated  by  the  presence  of
transmembrane or soluble selectins since expression
of selectins arise following activation while selectin
ligands  are  constitutively  present  on  plasma  mem-
brane and are not modulated by IL-1b stimulation. At
present, we cannot exclude that the structure binding
E- or P-selectins highlighted on endothelial cells in our
experiments are the well-known L-selectin ligands. In
fact it has been reported that an E-selectin-Ig chimera
specifically stained HEV in mouse lymph nodes, as did
an L-selectin-Ig  chimera and precipitated GlyCAM-1
and CD34/Sgp90 although  with less efficiency than
L-selectin.18 In any case, the finding of expression of
cognate ligands for P-selectins is a novelty.
Since ligands for E- and P-selectins acts mainly as
counter-receptor for adhesion molecules and mediate
rolling and adhesion of inflammatory or cancer cells
on endothelium we checked if the one expressed on
HUVEC  cells  are  able  to  mediate  adherence  to
immobilized selectins through static adhesion assays.
Unexpectedly, trypsinizated HUVEC cells were unable
to adhere to E- or P-selectins even when stimulated
with IL-1b according to the no increased expression
of  the  selectin  ligands  after  cytokine  treatment.
Trypsinization  was  not  a  limiting  step  in  adhesion
since it did not alter the expression of selectin ligands.
In  fact,  HUVEC  cells  exposed  to  trypsinization
showed an immunoreactivity for the complex able to
bind cognate ligands for P-selectins similar to the one
observed  in  HL-60  in  FACS  analysis,  although  this
methodology was less sensitive than cell-ELISA (our
unpublished  observation). There  was  a  pharmaco-
logical and functional difference in mediating adhe-
sion  response  between  selectin  cognate  ligands
expressed on HUVEC and myeloid or cancer cells. The
absence  of  HUVEC  adhesion  to  selectins  could  be
linked to  the  dissimilarity  in their  molecular  struc-
tures but also to the unfavourable setting for endothe-
lial  cells  or  to  a  low  or  inappropriate  density  of
selectin ligands expression. However, the structural
differences between cognate ligands for selectins on
HUVEC  and  HL-60  cells  were  pointed  out  by  the
immunoreactivity  for  the  MoAb  anti-sialyl-Lewis  X
(CSLEX1). Specific carbohydrate structures can func-
tion as ligands for  selectins,  interacting,  at  least  in
part,  with  their  lectin  domains.19–21 In  general,
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FIG. 1. Tube formation in Matrigel by HUVEC cells in the absence (A) or in the presence (B) of bFGF (20ng/ml).
FIG. 2. Effect of bFGF and soluble E- and P-selectins on tube
formation in Matrigel by HUVEC cells. The number of tube-
like structures in unstimulated cells was 19 ± 2.ligands for E- and P-selectins bear moieties of sialyl-
Lewis  X.5 The  antibody  CSLEX1,  which  is  able  to
inhibit the E- or P-selectin-mediated adhesion for non-
lymphoid  leukocytes  and  tumour  cells  of  diverse
origin11,15 was strongly recognized on HL-60 cells but
not on HUVEC cells. However, we cannot rule out
that  sialyl-Lewis X moieties are present on cognate
ligands for selectins expressed on HUVEC cells since
monoclonal antibodies anti-sialyl-Lewis X (FH-6 and
KM-93) other than CSLEX1 were strongly recognized
by HUVEC cells.22
It has been reported that  selectins contribute to
angiogenesis but their relevance in neovascular devel-
opment has been debated. Besides the effect of E- and
P-selectin  in  HUVEC  chemotaxis,3,6 we  gathered
evidence that they were not effective in switching on/
off  the  programme  of  formation  of  capillary-like
structures on Matrigel. This event is a defined process
that  does  not  require  extensive  proliferation  and
where  only some  aspects  of endothelial  cell  differ-
entiation  are  involved.23 Therefore,  we  cannot
exclude  that  in  different  experimental  conditions
(other  extracellular  matrix  proteins  or  endothelial
cells with different origins) selectins and their ligands
could  participate in the endothelial morphogenetic
process.  In  addition,  membrane  selectins  are  not
important in HUVEC capillary organization on Matri-
gel since neutralizing monoclonal antibodies directed
against  cell-surface  E-  or  P-selectins  did not  inhibit
basal  or  bFGF-induced  tube-formation.  This  is  in
agreement  with  a  recent  paper  describing  that
endothelial cells from E-selectin deficient mice form,
without alteration, capillary-like structures on fibro-
nectin, Matrigel and collagen gels in vitro.24
In  conclusion,  we  have  demonstrated  the  con-
stitutive presence of E- and P-selectin cognate ligands
on HUVEC cells that points out a new role(s) for this
class of adhesion molecules as signalling factors for
endothelial cells themselves.
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